The Report by M.-C. King et al. estimates breast cancer risks in carriers of the Ashkenazi Jewish founder mutations in BRCA1 and BRCA2 (“Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 ,” 24 Oct. 2003, p. [643][1]). The analysis was based on data from relatives of